<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33427209</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2379-3708</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>JCI insight</Title><ISOAbbreviation>JCI Insight</ISOAbbreviation></Journal><ArticleTitle>Matrin 3 in neuromuscular disease: physiology and pathophysiology.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e143948</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1172/jci.insight.143948</ELocationID><ELocationID EIdType="pii" ValidYN="Y">143948</ELocationID><Abstract><AbstractText>RNA-binding proteins (RBPs) are essential factors required for the physiological function of neurons, muscle, and other tissue types. In keeping with this, a growing body of genetic, clinical, and pathological evidence indicates that RBP dysfunction and/or gene mutation leads to neurodegeneration and myopathy. Here, we summarize the current understanding of matrin 3 (MATR3), a poorly understood RBP implicated not only in ALS and frontotemporal dementia but also in distal myopathy. We begin by reviewing MATR3's functions, its regulation, and how it may be involved in both sporadic and familial neuromuscular disease. We also discuss insights gleaned from cellular and animal models of MATR3 pathogenesis, the links between MATR3 and other disease-associated RBPs, and the mechanisms underlying RBP-mediated disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Medical Scientist Training Program.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Graduate Program, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barmada</LastName><ForeName>Sami J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Neuroscience Graduate Program, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F31 NS110119</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS097542</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007863</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCI Insight</MedlineTA><NlmUniqueID>101676073</NlmUniqueID><ISSNLinking>2379-3708</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C518587">MATR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034521">Nuclear Matrix-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C573692">matrin-3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049310" MajorTopicYN="N">Distal Myopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="N">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034521" MajorTopicYN="N">Nuclear Matrix-Associated Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> The authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>11</Day><Hour>8</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33427209</ArticleId><ArticleId IdType="pmc">PMC7821588</ArticleId><ArticleId IdType="doi">10.1172/jci.insight.143948</ArticleId><ArticleId IdType="pii">143948</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, et al. Decoding ALS: from genes to mechanism. Nature. 2016;539(7628):197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu H, Berezney R. Nuclear matrins: identification of the major nuclear matrix proteins. Proc Natl Acad Sci U S A. 1991;88(22):10312&#x2013;10316. doi: 10.1073/pnas.88.22.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.22.10312</ArticleId><ArticleId IdType="pmc">PMC52918</ArticleId><ArticleId IdType="pubmed">1946450</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgrader P, Dey R, Berezney R. Molecular cloning of matrin 3. A 125-kilodalton protein of the nuclear matrix contains an extensive acidic domain. J Biol Chem. 1991;266(15):9893&#x2013;9899.</Citation><ArticleIdList><ArticleId IdType="pubmed">2033075</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, et al. Involvement of phosphorylation in binding of nuclear scaffold proteins from rat liver to a highly repetitive DNA component. Biochim Biophys Acta. 1998;1396(1):88&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">9524232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, et al. Purification and characterization of nuclear scaffold proteins which bind to a highly repetitive bent DNA from rat liver. Biochim Biophys Acta. 1993;1174(2):162&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">8357833</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, et al. Properties of a DNA-binding protein from rat nuclear scaffold fraction. Biochem Biophys Res Commun. 1993;197(1):336&#x2013;342. doi: 10.1006/bbrc.1993.2480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1993.2480</ArticleId><ArticleId IdType="pubmed">8250943</ArticleId></ArticleIdList></Reference><Reference><Citation>Brayer KJ, et al. The protein-binding potential of C2H2 zinc finger domains. Cell Biochem Biophys. 2008;51(1):9&#x2013;19. doi: 10.1007/s12013-008-9007-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-008-9007-6</ArticleId><ArticleId IdType="pubmed">18286240</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdach J, et al. Two-timing zinc finger transcription factors liaising with RNA. Trends Biochem Sci. 2012;37(5):199&#x2013;205. doi: 10.1016/j.tibs.2012.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2012.02.001</ArticleId><ArticleId IdType="pubmed">22405571</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, et al. Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim Biophys Acta. 2006;1759(5):195&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16814881</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig JM, et al. Scaffold attachments within the human genome. J Cell Sci. 1997;110(Pt 21):2673&#x2013;2682.</Citation><ArticleIdList><ArticleId IdType="pubmed">9427385</ArticleId></ArticleIdList></Reference><Reference><Citation>Poljak L, K&#xe4;s E. Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol. 1995;5(9):348&#x2013;354. doi: 10.1016/S0962-8924(00)89068-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0962-8924(00)89068-6</ArticleId><ArticleId IdType="pubmed">14732077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerdes MG, et al. Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halos. J Cell Biol. 1994;126(2):289&#x2013;304. doi: 10.1083/jcb.126.2.289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.126.2.289</ArticleId><ArticleId IdType="pmc">PMC2200020</ArticleId><ArticleId IdType="pubmed">8034736</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh GB, et al. Mathematical model to predict regions of chromatin attachment to the nuclear matrix. Nucleic Acids Res. 1997;25(7):1419&#x2013;1425. doi: 10.1093/nar/25.7.1419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/25.7.1419</ArticleId><ArticleId IdType="pmc">PMC146595</ArticleId><ArticleId IdType="pubmed">9060438</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu H, Berezney R. Mapping replicational sites in the eucaryotic cell nucleus. J Cell Biol. 1989;108(1):1&#x2013;11. doi: 10.1083/jcb.108.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.108.1.1</ArticleId><ArticleId IdType="pmc">PMC2115357</ArticleId><ArticleId IdType="pubmed">2910875</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayler O, et al. SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. Nucleic Acids Res. 1998;26(15):3542&#x2013;3549. doi: 10.1093/nar/26.15.3542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/26.15.3542</ArticleId><ArticleId IdType="pmc">PMC147731</ArticleId><ArticleId IdType="pubmed">9671816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidwell JP, et al. Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci U S A. 1993;90(8):3162&#x2013;3166. doi: 10.1073/pnas.90.8.3162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.8.3162</ArticleId><ArticleId IdType="pmc">PMC46259</ArticleId><ArticleId IdType="pubmed">8475055</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeitz MJ, Malyavantham KS, Seifert B, Berezney R. Matrin 3: chromosomal distribution and protein interactions. J Cell Biochem. 2009;108(1):125&#x2013;133. doi: 10.1002/jcb.22234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22234</ArticleId><ArticleId IdType="pubmed">19562669</ArticleId></ArticleIdList></Reference><Reference><Citation>Malyavantham KS, et al. Identifying functional neighborhoods within the cell nucleus: proximity analysis of early S-phase replicating chromatin domains to sites of transcription, RNA polymerase II, HP1gamma, matrin 3 and SAF-A. J Cell Biochem. 2008;105(2):391&#x2013;403. doi: 10.1002/jcb.21834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.21834</ArticleId><ArticleId IdType="pmc">PMC2705756</ArticleId><ArticleId IdType="pubmed">18618731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, Ohzeki H, Sugano N, Hiraga K. Transcription modulation by a rat nuclear scaffold protein, P130, and a rat highly repetitive DNA component or various types of animal and plant matrix or scaffold attachment regions. Biochem Biophys Res Commun. 2000;279(1):282&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">11112453</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronska-Krawczyk D, et al. Required enhancer-matrin-3 network interactions for a homeodomain transcription program. Nature. 2014;514(7521):1&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4358797</ArticleId><ArticleId IdType="pubmed">25119036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita T, Fujii H. Direct identification of insulator components by insertional chromatin immunoprecipitation. PLoS One. 2011;6(10):e26109. doi: 10.1371/journal.pone.0026109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026109</ArticleId><ArticleId IdType="pmc">PMC3197142</ArticleId><ArticleId IdType="pubmed">22043306</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M, et al. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle. 2014;9(8):1568&#x2013;1576.</Citation><ArticleIdList><ArticleId IdType="pubmed">20421735</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi L, et al. Matrin3 promotes homologous recombinational repair by regulation of RAD51. J Biochem. 2019;166(4):343&#x2013;351. doi: 10.1093/jb/mvz041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvz041</ArticleId><ArticleId IdType="pubmed">31119278</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary R, et al. Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3. Elife. 2017;6:861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470874</ArticleId><ArticleId IdType="pubmed">28580901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajgor D, et al. Identification of novel nesprin-1 binding partners and cytoplasmic matrin-3 in processing bodies. Mol Biol Cell. 2016;27(24):3894&#x2013;3902. doi: 10.1091/mbc.E16-06-0346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-06-0346</ArticleId><ArticleId IdType="pmc">PMC5170611</ArticleId><ArticleId IdType="pubmed">27733621</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;ck J, et al. Proteomic and functional analysis of argonaute-containing mRNA-protein complexes in human cells. EMBO Rep. 2007;8(11):1052&#x2013;1060. doi: 10.1038/sj.embor.7401088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7401088</ArticleId><ArticleId IdType="pmc">PMC2247381</ArticleId><ArticleId IdType="pubmed">17932509</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M, et al. Matrin 3 binds and stabilizes mRNA. PLoS One. 2011;6(8):e23882&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3157474</ArticleId><ArticleId IdType="pubmed">21858232</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo E-C, et al. Large-scale tethered function assays identify factors that regulate mRNA stability and translation. Nat Struct Mol Biol. 2020;24(10):416&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayala YM, et al. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol. 2005;348(3):575&#x2013;588. doi: 10.1016/j.jmb.2005.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2005.02.038</ArticleId><ArticleId IdType="pubmed">15826655</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo P-H, et al. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009;37(6):1799&#x2013;1808. doi: 10.1093/nar/gkp013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp013</ArticleId><ArticleId IdType="pmc">PMC2665213</ArticleId><ArticleId IdType="pubmed">19174564</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem. 2001;276(39):36337&#x2013;36343. doi: 10.1074/jbc.M104236200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104236200</ArticleId><ArticleId IdType="pubmed">11470789</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho MB, et al. Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J. 2015;34(5):653&#x2013;668. doi: 10.15252/embj.201489852.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201489852</ArticleId><ArticleId IdType="pmc">PMC4365034</ArticleId><ArticleId IdType="pubmed">25599992</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss K, et al. The nuclear matrix protein Matr3 regulates processing of the synaptic microRNA-138-5p. Neurobiol Learn Mem. 2019;159:36&#x2013;45. doi: 10.1016/j.nlm.2019.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nlm.2019.02.008</ArticleId><ArticleId IdType="pubmed">30790622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray D, et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature. 2013;499(7457):172&#x2013;177. doi: 10.1038/nature12311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12311</ArticleId><ArticleId IdType="pmc">PMC3929597</ArticleId><ArticleId IdType="pubmed">23846655</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y, et al. Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cells. 2017;22(9):785&#x2013;798. doi: 10.1111/gtc.12512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12512</ArticleId><ArticleId IdType="pubmed">28695676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J, et al. Modulation of PDCD1 exon 3 splicing. RNA Biol. 2019;16(12):1794&#x2013;1805. doi: 10.1080/15476286.2019.1659080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2019.1659080</ArticleId><ArticleId IdType="pmc">PMC6844568</ArticleId><ArticleId IdType="pubmed">31441370</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A, et al. Crystallographic analysis of polypyrimidine tract-binding protein-Raver1 interactions involved in regulation of alternative splicing. Structure. 2011;19(12):1816&#x2013;1825. doi: 10.1016/j.str.2011.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2011.09.020</ArticleId><ArticleId IdType="pmc">PMC3420021</ArticleId><ArticleId IdType="pubmed">22153504</ArticleId></ArticleIdList></Reference><Reference><Citation>Attig J, et al. Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing. Cell. 2018;174(5):1067&#x2013;1081.e17. doi: 10.1016/j.cell.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.001</ArticleId><ArticleId IdType="pmc">PMC6108849</ArticleId><ArticleId IdType="pubmed">30078707</ArticleId></ArticleIdList></Reference><Reference><Citation>Morchikh M, et al. HEXIM1 and NEAT1 long non-coding RNA form a multi-subunit complex that regulates DNA-mediated innate immune response. Mol Cell. 2017;67(3):387&#x2013;399.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28712728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi A, Takanashi K. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription. Sci Rep. 2016;6:35195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5059712</ArticleId><ArticleId IdType="pubmed">27731383</ArticleId></ArticleIdList></Reference><Reference><Citation>Damianov A, et al. Rbfox proteins regulate splicing as part of a large multiprotein complex LASR. Cell. 2016;165(3):606&#x2013;619. doi: 10.1016/j.cell.2016.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.03.040</ArticleId><ArticleId IdType="pmc">PMC4841943</ArticleId><ArticleId IdType="pubmed">27104978</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, et al. Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network. Brain Res. 2016;1647:79&#x2013;93. doi: 10.1016/j.brainres.2016.02.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.047</ArticleId><ArticleId IdType="pmc">PMC5152586</ArticleId><ArticleId IdType="pubmed">26979993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenzer S, et al. Proteome-wide characterization of the RNA-binding protein RALY-interactome using the in vivo-biotinylation-pulldown-quant (iBioPQ) approach. J Proteome Res. 2013;12(6):2869&#x2013;2884. doi: 10.1021/pr400193j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400193j</ArticleId><ArticleId IdType="pubmed">23614458</ArticleId></ArticleIdList></Reference><Reference><Citation>Erazo A, Goff SP. Nuclear matrix protein Matrin 3 is a regulator of ZAP-mediated retroviral restriction. Retrovirology. 2015;12:1&#x2013;12. doi: 10.1186/s12977-014-0129-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12977-014-0129-1</ArticleId><ArticleId IdType="pmc">PMC4487854</ArticleId><ArticleId IdType="pubmed">26129669</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, et al. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A. 2010;107(30):13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard D, et al. hLodestar/HuF2 interacts with CDC5L and is involved in pre-mRNA splicing. Biochem Biophys Res Commun. 2003;308(4):793&#x2013;801. doi: 10.1016/S0006-291X(03)01486-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-291X(03)01486-4</ArticleId><ArticleId IdType="pubmed">12927788</ArticleId></ArticleIdList></Reference><Reference><Citation>et al. ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci Rep. 2017;7(1):1&#x2013;14. doi: 10.1038/s41598-016-0028-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-016-0028-x</ArticleId><ArticleId IdType="pmc">PMC5674072</ArticleId><ArticleId IdType="pubmed">29109432</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik AM, et al. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife. 2018;7:602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Iradi MCG, et al. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci Rep. 2018;8(1):4049. doi: 10.1038/s41598-018-21371-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21371-4</ArticleId><ArticleId IdType="pmc">PMC5840295</ArticleId><ArticleId IdType="pubmed">29511296</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego-Iradi MC, et al. N-terminal sequences in matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements. Lab Invest. 2019;99(7):1030&#x2013;1040. doi: 10.1038/s41374-019-0260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0260-7</ArticleId><ArticleId IdType="pmc">PMC6857798</ArticleId><ArticleId IdType="pubmed">31019288</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores BN, et al. An intramolecular salt bridge linking TDP43 RNA binding, protein stability, and TDP43-dependent neurodegeneration. Cell Rep. 2019;27(4):1133&#x2013;1150.e8. doi: 10.1016/j.celrep.2019.03.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.03.093</ArticleId><ArticleId IdType="pmc">PMC6499398</ArticleId><ArticleId IdType="pubmed">31018129</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S, et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science. 2018;360(6391):eaar7366&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102(2):321&#x2013;338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, et al. Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Res. 2017;45(18):10706&#x2013;10725. doi: 10.1093/nar/gkx786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx786</ArticleId><ArticleId IdType="pmc">PMC5737383</ArticleId><ArticleId IdType="pubmed">28977530</ArticleId></ArticleIdList></Reference><Reference><Citation>Depreux FF, et al. Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. Hum Mol Genet. 2015;24(15):4284&#x2013;4295. doi: 10.1093/hmg/ddv160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv160</ArticleId><ArticleId IdType="pmc">PMC4492393</ArticleId><ArticleId IdType="pubmed">25948554</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintero-Rivera F, et al. MATR3 disruption in human and mouse associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus. Hum Mol Genet. 2015;24(8):2375&#x2013;2389. doi: 10.1093/hmg/ddv004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv004</ArticleId><ArticleId IdType="pmc">PMC4380077</ArticleId><ArticleId IdType="pubmed">25574029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Long-read RNA sequencing identifies alternative splice variants in hepatocellular carcinoma and tumor-specific isoforms. Hepatology. 2019;70(3):1011&#x2013;1025. doi: 10.1002/hep.30500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.30500</ArticleId><ArticleId IdType="pmc">PMC6766942</ArticleId><ArticleId IdType="pubmed">30637779</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S, et al. Heterogeneity of Matrin 3 in the developing and aging murine central nervous system. J Comp Neurol. 2016;524(14):2740&#x2013;2752. doi: 10.1002/cne.23986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23986</ArticleId><ArticleId IdType="pmc">PMC5832027</ArticleId><ArticleId IdType="pubmed">26878116</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano G, et al. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J Neurochem. 2005;94(3):808&#x2013;818. doi: 10.1111/j.1471-4159.2005.03235.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03235.x</ArticleId><ArticleId IdType="pubmed">16000164</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia CA, Ju W, Liu R. Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases. Biochem Biophys Res Commun. 2007;361(2):281&#x2013;286. doi: 10.1016/j.bbrc.2007.06.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.06.156</ArticleId><ArticleId IdType="pubmed">17658460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, Fass DM, Reynolds IJ. Emergence of excitotoxicity in cultured forebrain neurons coincides with larger glutamate-stimulated [Ca(2+)](i) increases and NMDA receptor mRNA levels. Brain Res. 1999;849(1-2):97&#x2013;108. doi: 10.1016/S0006-8993(99)01995-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(99)01995-2</ArticleId><ArticleId IdType="pubmed">10592291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisada-Ishii S, et al. Bipartite nuclear localization signal of matrin 3 is essential for vertebrate cells. Biochem Biophys Res Commun. 2007;354(1):72&#x2013;76. doi: 10.1016/j.bbrc.2006.12.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.12.191</ArticleId><ArticleId IdType="pubmed">17223080</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein L, Trescott OH. Characterization of RNAs that do and do not migrate between cytoplasm and nucleus. Proc Natl Acad Sci U S A. 1970;67(3):1367&#x2013;1374. doi: 10.1073/pnas.67.3.1367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.67.3.1367</ArticleId><ArticleId IdType="pmc">PMC283361</ArticleId><ArticleId IdType="pubmed">5274464</ArticleId></ArticleIdList></Reference><Reference><Citation>Erazo A, et al. The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3. J Virol. 2010;85(1):568&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3014177</ArticleId><ArticleId IdType="pubmed">20962082</ArticleId></ArticleIdList></Reference><Reference><Citation>Niimori-Kita K, et al. Matrin-3 is essential for fibroblast growth factor 2-dependent maintenance of neural stem cells. Sci Rep. 2018;8(1):13412. doi: 10.1038/s41598-018-31597-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31597-x</ArticleId><ArticleId IdType="pmc">PMC6128890</ArticleId><ArticleId IdType="pubmed">30194346</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki F, et al. pY RNA1-s2: a highly retina-enriched small RNA that selectively binds to Matrin 3 (Matr3) PLoS One. 2014;9(2):e88217. doi: 10.1371/journal.pone.0088217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0088217</ArticleId><ArticleId IdType="pmc">PMC3928194</ArticleId><ArticleId IdType="pubmed">24558381</ArticleId></ArticleIdList></Reference><Reference><Citation>Feit H, et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet. 1998;63(6):1732&#x2013;1742. doi: 10.1086/302166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/302166</ArticleId><ArticleId IdType="pmc">PMC1377645</ArticleId><ArticleId IdType="pubmed">9837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderek J, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet. 2009;84(4):511&#x2013;518. doi: 10.1016/j.ajhg.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC2667977</ArticleId><ArticleId IdType="pubmed">19344878</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraya T, et al. Impairment of respiratory function in late-onset distal myopathy due to MATR3 mutation. Muscle Nerve. 2015;51(6):916&#x2013;918. doi: 10.1002/mus.24603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24603</ArticleId><ArticleId IdType="pubmed">25677933</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmio J, et al. Re-evaluation of the phenotype caused by the common MATR3 p.Ser85Cys mutation in a new family. J Neurol Neurosurg Psychiatry. 2016;87(4):448&#x2013;450. doi: 10.1136/jnnp-2014-309349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309349</ArticleId><ArticleId IdType="pubmed">25952333</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller TJ, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol. 2014;76(5):669&#x2013;680. doi: 10.1002/ana.24255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24255</ArticleId><ArticleId IdType="pubmed">25154462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensch A, et al. Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination. J Neurol. 2020;14(3):434&#x2013;2420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358922</ArticleId><ArticleId IdType="pubmed">32361838</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensch A, et al. The p.S85C-mutation in MATR3 impairs stress granule formation in Matrin-3 myopathy. Exp Neurol. 2018;306:222&#x2013;231. doi: 10.1016/j.expneurol.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.05.012</ArticleId><ArticleId IdType="pubmed">29763601</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17(5):664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, et al. Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation. Neuropathol Appl Neurobiol. 2015;41(3):391&#x2013;398. doi: 10.1111/nan.12179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12179</ArticleId><ArticleId IdType="pubmed">25185957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch F, Kraya T, M&#xfc;ller T, Kornhuber M. Needle electromyography findings in patients with MATR3 mutation - a prospective study. Clin Neurophysiol. 2016;127(4):2085&#x2013;2086. doi: 10.1016/j.clinph.2015.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2015.12.008</ArticleId><ArticleId IdType="pubmed">26899464</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch F, et al. The significance of pathological spontaneous activity in various myopathies. Clin Neurophysiol. 2014;125(7):1485&#x2013;1490. doi: 10.1016/j.clinph.2013.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2013.11.021</ArticleId><ArticleId IdType="pubmed">24370491</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17(5):664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K-P, et al. Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging. 2015;36(5):2005.e1&#x2013;2005.e4. doi: 10.1016/j.neurobiolaging.2015.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.008</ArticleId><ArticleId IdType="pubmed">25771394</ArticleId></ArticleIdList></Reference><Reference><Citation>Origone P, et al. A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):530&#x2013;531. doi: 10.3109/21678421.2015.1058397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1058397</ArticleId><ArticleId IdType="pubmed">26199109</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, et al. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2016;37(C):209.e17&#x2013;209.e21.</Citation><ArticleIdList><ArticleId IdType="pubmed">26493020</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, et al. Matrin 3 variants are frequent in Italian ALS patients. Neurobiol Aging. 2017;49(C):218.e1&#x2013;218.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">28029397</ArticleId></ArticleIdList></Reference><Reference><Citation>Narain P, et al. Identification and characterization of novel and rare susceptible variants in Indian amyotrophic lateral sclerosis patients. Neurogenetics. 2019;20(4):197&#x2013;208. doi: 10.1007/s10048-019-00584-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-019-00584-3</ArticleId><ArticleId IdType="pubmed">31432357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamp M, et al. Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients. Neurobiol Aging. 2018;66:179.e5&#x2013;179.e16. doi: 10.1016/j.neurobiolaging.2018.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.01.013</ArticleId><ArticleId IdType="pubmed">29525178</ArticleId></ArticleIdList></Reference><Reference><Citation>Barp A, et al. The first French case of MATR3-related distal myopathy: clinical, radiological and histopathological characterization. Rev Neurol (Paris) 2018;174(10):752&#x2013;755. doi: 10.1016/j.neurol.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2017.08.004</ArticleId><ArticleId IdType="pubmed">29628183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A, et al. The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 2017;24(10):1&#x2013;1671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AR, et al. Stratified gene expression analysis identifies major amyotrophic lateral sclerosis genes. Neurobiol Aging. 2015;36(5):2006.e1&#x2013;2006.e9. doi: 10.1016/j.neurobiolaging.2015.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.017</ArticleId><ArticleId IdType="pubmed">25801576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M, et al. Matrin 3 Is a Component of neuronal cytoplasmic inclusions of motor neurons in sporadic amyotrophic lateral sclerosis. Am J Pathol. 2017;188(2):1&#x2013;514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29128563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamoah A, et al. Aggregates of RNA binding proteins and ER chaperones linked to exosomes in granulovacuolar degeneration of the Alzheimer&#x2019;s disease brain. J Alzheimers Dis. 2020;75(1):139&#x2013;156. doi: 10.3233/JAD-190722.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190722</ArticleId><ArticleId IdType="pubmed">32250292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zatsepina OG, et al. Amyloid-&#x3b2; with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation. Sci Rep. 2018;8(1):3518. doi: 10.1038/s41598-018-21815-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21815-x</ArticleId><ArticleId IdType="pmc">PMC5824883</ArticleId><ArticleId IdType="pubmed">29476081</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego-Iradi MC, et al. Subcellular localization of Matrin 3 containing mutations associated with ALS and distal myopathy. PLoS One. 2015;10(11):e0142144&#x2013;15. doi: 10.1371/journal.pone.0142144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142144</ArticleId><ArticleId IdType="pmc">PMC4631352</ArticleId><ArticleId IdType="pubmed">26528920</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LR, et al. C9orf72 arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import. Elife. 2020;9:807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7051184</ArticleId><ArticleId IdType="pubmed">32119645</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, et al. Identification of proteins sensitive to thermal stress in human neuroblastoma and glioma cell lines. PLoS One. 2012;7(11):e49021. doi: 10.1371/journal.pone.0049021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049021</ArticleId><ArticleId IdType="pmc">PMC3493505</ArticleId><ArticleId IdType="pubmed">23145051</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajc &#x10c;esnik A, Motaln H, Rogelj B. The impact of ALS-associated genes hnRNPA1, MATR3, VCP and UBQLN2 on the severity of TDP-43 aggregation. Cells. 2020;9(8):E1791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465640</ArticleId><ArticleId IdType="pubmed">32731393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, et al. Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila. FEBS Lett. 2020;27(17):4103.</Citation><ArticleIdList><ArticleId IdType="pubmed">32515490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N, et al. RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM. Acta Neuropathol Commun. 2020;8(1):138. doi: 10.1186/s40478-020-01021-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01021-5</ArticleId><ArticleId IdType="pmc">PMC7437177</ArticleId><ArticleId IdType="pubmed">32811564</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao CS, et al. Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS. Nat Commun. 2020;11(1):5304&#x2013;5317. doi: 10.1038/s41467-020-18949-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18949-w</ArticleId><ArticleId IdType="pmc">PMC7576598</ArticleId><ArticleId IdType="pubmed">33082323</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney C, et al. Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3. Acta Neuropathol Commun. 2018;6(1):137. doi: 10.1186/s40478-018-0631-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0631-0</ArticleId><ArticleId IdType="pmc">PMC6299607</ArticleId><ArticleId IdType="pubmed">30563574</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, et al. A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal. 1996;13(6):159&#x2013;163. doi: 10.1016/S1050-3862(96)00167-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1050-3862(96)00167-2</ArticleId><ArticleId IdType="pubmed">9117892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, et al. A mutant MATR3 mouse model to explain multisystem proteinopathy. J Pathol. 2019;249(2):182&#x2013;192. doi: 10.1002/path.5289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5289</ArticleId><ArticleId IdType="pubmed">31056746</ArticleId></ArticleIdList></Reference><Reference><Citation>Askanas V, et al. Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochim Biophys Acta. 2015;1852(4):633&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">25241263</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495(7442):467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai RM, et al. Involvement of valosin-containing protein, an ATPase co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem. 1998;273(6):3562&#x2013;3573. doi: 10.1074/jbc.273.6.3562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.6.3562</ArticleId><ArticleId IdType="pubmed">9452483</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol. 2001;3(8):740&#x2013;744. doi: 10.1038/35087056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35087056</ArticleId><ArticleId IdType="pubmed">11483959</ArticleId></ArticleIdList></Reference><Reference><Citation>Custer SK, et al. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet. 2010;19(9):1741&#x2013;1755. doi: 10.1093/hmg/ddq050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq050</ArticleId><ArticleId IdType="pubmed">20147319</ArticleId></ArticleIdList></Reference><Reference><Citation>Badadani M, et al. VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One. 2010;5(10):e13183. doi: 10.1371/journal.pone.0013183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013183</ArticleId><ArticleId IdType="pmc">PMC2950155</ArticleId><ArticleId IdType="pubmed">20957154</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke KA, Janke AM, Rhine CL, Fawzi NL. Residue-by-residue view of in vitro FUS granules that bind the C-terminal domain of RNA polymerase II. Mol Cell. 2015;60(2):231&#x2013;241. doi: 10.1016/j.molcel.2015.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.09.006</ArticleId><ArticleId IdType="pmc">PMC4609301</ArticleId><ArticleId IdType="pubmed">26455390</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z, et al. Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO J. 2017;36(20):2951&#x2013;2967. doi: 10.15252/embj.201696394.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray DT, et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell. 2017;171(3):615&#x2013;627.e16. doi: 10.1016/j.cell.2017.08.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.08.048</ArticleId><ArticleId IdType="pmc">PMC5650524</ArticleId><ArticleId IdType="pubmed">28942918</ArticleId></ArticleIdList></Reference><Reference><Citation>Qamar S, et al. FUS phase separation is modulated by a molecular chaperone and methylation of arginine cation-&#x3c0; interactions. Cell. 2018;173(3):720&#x2013;734.e15. doi: 10.1016/j.cell.2018.03.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.056</ArticleId><ArticleId IdType="pmc">PMC5927716</ArticleId><ArticleId IdType="pubmed">29677515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofweber M, et al. Phase separation of FUS is suppressed by its nuclear import receptor and arginine methylation. Cell. 2018;173(3):706&#x2013;719.e13. doi: 10.1016/j.cell.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.004</ArticleId><ArticleId IdType="pubmed">29677514</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar J, Perrois C, Heim M, Bousset L, Alberti S, Besse F. The prion-like domain of Drosophila Imp promotes axonal transport of RNP granules in vivo. Nat Commun. 2019;10(1):2593. doi: 10.1038/s41467-019-10554-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10554-w</ArticleId><ArticleId IdType="pmc">PMC6565635</ArticleId><ArticleId IdType="pubmed">31197139</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325&#x2013;345.e28. doi: 10.1016/j.cell.2020.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.046</ArticleId><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88(4):678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162(5):1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, et al. ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24(9):1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, et al. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proc Natl Acad Sci U S A. 2017;114(12):E2466&#x2013;E2475. doi: 10.1073/pnas.1614462114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D, et al. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017;36(12):1669&#x2013;1687. doi: 10.15252/embj.201695957.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695957</ArticleId><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>Saez-Atienzar S, et al. Identification of a pathogenic intronic KIF5A mutation in an ALS-FTD kindred. Neurology. 2020;5(22):5&#x2013;1018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734922</ArticleId><ArticleId IdType="pubmed">33077544</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollini D, et al. Generation and characterization of a human iPSC line from an ALS patient carrying the Q66K-MATR3 mutation. Stem Cell Res. 2018;33:146&#x2013;150. doi: 10.1016/j.scr.2018.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.10.011</ArticleId><ArticleId IdType="pubmed">30366341</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22(2):167&#x2013;179. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22(2):180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K, et al. Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics. 2006;7(1):208. doi: 10.1186/1471-2105-7-208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-7-208</ArticleId><ArticleId IdType="pmc">PMC1479845</ArticleId><ArticleId IdType="pubmed">16618368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>